Supernus Pharmaceuticals, Inc. Tech Stack
CNS-focused pharma commercializing ADHD, migraine, epilepsy, and Parkinson's treatments
Supernus is a public pharmaceutical company specializing in central nervous system disorders, with six FDA-approved products on the market and a pipeline of development candidates. The company runs its own U.S. specialty sales force while pursuing licensing partnerships internationally. Hiring is concentrated in sales (30 roles) and healthcare operations (14 roles), reflecting a commercialization-heavy posture; the tech stack leans heavily on pharmaceutical operations tools (Veeva, SAS, XBRL, Workiva) and compliance infrastructure, with pain points centered on SOX and Good Pharmaceutical Practice adherence, manufacturing scale-up, and managed-care access barriers.
Tech Stack 23 technologies
What Supernus Pharmaceuticals, Inc. Is Building
◆Challenges
- Ensuring compliance with gpp guidelines
- Managing sox compliance
- Compliance with sox requirements
- Ensuring consistency and accuracy of adverse event reporting
- Manufacturing scale up
- Patient access challenges
- Policy changes
- Coverage barriers
- Scouting new m&a opportunities
- Improving production efficiencies
▲Active Projects
- Customer support outside of designated territory
- Pre-launch initiatives
- Managed care pull-through programs
- Launches
- Implementing purchasing cards (p-cards)
- Medical affairs training programs
- M&a opportunity scouting
- Post deal integration
- R&d credit studies
- State tax nexus studies
Hiring Activity
Department
Seniority
Notable leadership hires: Medical Director, Government Affairs Director
